BCL2 and lung cancer: We next analyzed the protein expression of oncogenes known to be transcriptionally upregulated in tuft cell-like lung cancer subsets, i.e., BCL2 [10, 16], MYC [15, 16, 30, 31], and KIT [17], because their expression might further delineate tuft cell-like variants and open new therapeutic perspectives.